Cidara could raise $35 million through at-the-market equity offering

Deal arranged with Cantor Fitzgerald; agent to be paid a 3% commission

By Devika Patel

Knoxville, Tenn., May 20 – Cidara Therapeutics, Inc. negotiated a $35 million at-the-market equity offering with agent Cantor Fitzgerald & Co. on May 19, according to an 8-K filed Friday with the Securities and Exchange Commission.

Cantor will be paid a 3% commission.

The biotechnology company is based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.